PHR250117P12500
- 0.60
- 0.000.00%
Phreesia Newsroom
Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High?
Phreesia (PHR) Receives a Buy From J.P. Morgan
There's Reason For Concern Over Phreesia, Inc.'s (NYSE:PHR) Massive 38% Price Jump
Phreesia Insider Sold Shares Worth $294,559, According to a Recent SEC Filing
Insider Sale: SVP of $PHR (PHR) Sells 11,853 Shares
Analysts Offer Insights on Healthcare Companies: Pharming Group (OtherPHGUF) and Phreesia (PHR)
RBC Capital Sticks to Its Hold Rating for Phreesia (PHR)
Phreesia Price Target Lowered to $30 From $34 at Baird
Phreesia, Inc. (NYSE:PHR): Is Breakeven Near?
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Truist Financial Maintains Phreesia(PHR.US) With Buy Rating, Announces Target Price $34
Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)
Phreesia Is Maintained at Buy by Truist Securities
Truist Financial Initiates Phreesia(PHR.US) With Buy Rating, Announces Target Price $34
A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $28 to $30
Truist Raises Price Target on Phreesia to $34 From $31, Keeps Buy Rating
Baird Maintains Outperform on Phreesia, Lowers Price Target to $30
Phreesia's Global Expansion: Navigating Legal Hurdles and Compliance Costs
JMP Securities Reiterates Market Outperform on Phreesia, Maintains $30 Price Target
Q3 2025 Phreesia Inc Earnings Call